PharmaBoardroom

China Biopharma Dealmaking 2020 Review

While many parts of the world ground to a halt as they tried to deal with the global pandemic, China had more or less brought the situation under…

2020’s Top 7 Biotech IPOs in Profile

Following the recent news of Remegen's massive USD 515 million IPO in November 2020, we bring you profiles of the seven biggest biotech companies to…

China: Sinopharm Vaccine Approval; Online Healthcare Boom; 51%…

The latest from Chinese pharma, including domestic regulatory approval for Sinopharm's COVID-19 vaccine, how the country's online healthcare industry…

Chinese Pharma Share Price Hit; Pfizer-LianBio Linkup; Novo’s…

The latest from Chinese pharma, including a drop in share prices for Chinese vaccine firms in the wake of successful COVID-19 trial results from…

Top 7 Biotech IPOs in 2020

Following the recent news of Remegen's massive USD 515 million IPO in November 2020, we bring you the seven biggest biotech IPOs this year. Notably,…

China: Hitgen Aims to Strengthen its “Innovation Foundation”…

PharmaBoardroom had the pleasure of interviewing HitGen chairman & CEO Dr Jin LI in July regarding the company’s focus on DNA-encoded chemical…

China: 2020’s Biggest Biotech IPO in Profile

RemeGen, a low-profile Chinese biotech company based in Yantai city in the coastal Shandong province, around nine hours by train from the bustling…

China: Green Valley Alzheimer’s Trial; Samsung Biologics…

A roundup of the latest from Chinese pharma, including Green Valley's upcoming US trial for an Alzheimer's drug inspired by algae; Samsung Biologics…

Four Cell & Gene Companies to Know in China

While cell and gene therapies are all the rage now, a little known fact is that the world’s first approved gene therapy actually came from a Chinese…

Edigene CEO on Gene Editing Biotech’s Ambitious Expansion Plans

Following a recent capital injection of USD 67 million, Chinese biotech EdiGene is set to advance its pipeline in gene editing treatments and…

Fosun Pharma Gearing Up to Bring mRNA COVID-19 Vaccine to China

The collaboration between BioNTech and Pfizer on a COVID-19 vaccine candidate based on mRNA technology continues apace, with hopes for an emergency…

China: The Pharma Deals Keep Coming

The latest from Chinese pharma, with dealmaking continuing apace. Featured this week are Zai Lab’s latest IPO listing in Hong Kong, InventisBio…

Tagged with china